Why Infinity Pharmaceuticals Shares Tumbled Around 38%; Here Are 79 Biggest Movers From Yesterday

Loading...
Loading...

Gainers

  • Opiant Pharmaceuticals, Inc. OPNT shares surged 113.8% to settle at $20.10 on Monday. Indivior PLC agreed to acquire Opiant Pharmaceuticals for $20.00 per share in cash, plus contingent value rights (CVRs) of up to $8.00 per share.
  • Freight Technologies, Inc. FRGT shares climbed 113.6% to close at $0.4410 on Monday after analysts at Chardan Capital initiated coverage of the stock with a $2.25 price target.
  • ToughBuilt Industries, Inc. TBLT shares gained 72.3% to close at $3.79 after the company reported better-than-expected Q3 EPS results.
  • Exela Technologies, Inc. XELA jumped 45.6% to close at $0.4048.
  • Porch Group, Inc. PRCH rose 37.3% to close at $1.40. The compamy recently posted a wider-than-expected quarterly loss.
  • Mercurity Fintech Holding Inc. MFH gained 36.1% to close at $0.7358.
  • Clovis Oncology, Inc. CLVS rose 32.6% to close at $0.3846. Clovis Oncology recently warned of a possible bankruptcy amid liquidity concerns.
  • Getty Images Holdings, Inc. GETY gained 31.3% to close at $6.97 after the company reported worse-than-expected Q3 results.
  • Cabaletta Bio, Inc. CABA jumped 30.7% to close at $3.11. Cabaletta Bio recently posted a Q3 loss of $0.39 per share.
  • MINISO Group Holding Limited MNSO jumped 29% to close at $9.12 after the company reported better-than-expected Q1 financial results.
  • Meta Materials Inc. MMAT surged 29% to close at $1.69.
  • Yiren Digital Ltd. YRD gained 27.7% to close at $1.29.
  • Insignia Systems, Inc. ISIG jumped 27.7% to close at $8.34. Insignia Systems recently posted Q3 EPS of $6.57.
  • Siyata Mobile Inc. SYTA rose 26.9% to close at $0.1650, possibly on continued strength after Zacks Small-Cap Research set a $2.50 price target on the stock.
  • PDS Biotechnology Corporation PDSB gained 26.1% to close at $7.06 after the company announced 100% clinical response in cervical cancer patients in preliminary data from the IMMUNOCERV Phase 2 clinical trial. The company also reported better-than-expected Q3 EPS results.
  • Onconova Therapeutics, Inc. ONTX gained 25.8% to close at $0.88 following Q3 results.
  • Immersion Corporation IMMR jumped 23.6% to close at $6.81. Immersion posted Q3 EPS of $0.28.
  • HireRight Holdings Corporation HRT climbed 23.5% to close at $9.52. HireRight’s board authorized a $100 million share repurchase program.
  • Ensysce Biosciences, Inc. ENSC gained 22.8% to close at $2.37 after the company announced it received written guidance from the FDA that an acute pain indication may be appropriate for its lead Trypsin Activated Abuse Protection product, PF614.
  • Starbox Group Holdings Ltd. STBX jumped 20.6% to close at $2.11.
  • Cosmos Holdings Inc. COSM gained 20.3% to close at $0.1480 after gaining 7% on Friday.
  • CNFinance Holdings Limited CNF gained 19.7% to close at $1.70.
  • Gaotu Techedu Inc. GOTU surged 19.2% to settle at $0.8888.
  • T2 Biosystems, Inc. TTOO jumped 18.4% to settle at $2.25.
  • Kidpik Corp. PIK climbed 18% to close at $1.05. KIDPIK is expected to release Q3 results on November 15, 2022.
  • GlycoMimetics, Inc. GLYC gained 16.9% to close at $1.45.
  • Agenus Inc. AGEN climbed 16.7% to close at $2.93. Agenus recently posted a Q3 loss of $0.19 per share.
  • Clear Secure, Inc. YOU rose 16.6% to close at $29.69 after the company reported better-than-expected Q3 sales results.
  • Dingdong (Cayman) Limited DDL surged 16.2% to close at $4.08. The company recently reported better-than-expected Q3 adjusted EPS results.
  • CIRCOR International, Inc. CIR gained 14.9% to close at $24.90 following better-than-expected quarterly results.
  • CureVac N.V. CVAC gained 12.5% to close at $8.27.
  • Armata Pharmaceuticals, Inc. ARMP gained 11.9% to close at $3.21. Armata Pharmaceuticals recently reported a Q3 loss of $0.24 per share.
  • Helius Medical Technologies, Inc. HSDT climbed 11.5% to close at $0.2899 following strong quarterly results.
  • HUTCHMED (China) Limited HCM climbed 10.9% to close at $10.98 after the company reported initial results from FRUTIGA. The company said the trial met one of the primary endpoints of statistically significant improvement in progression-free survival.
  • Daseke, Inc. DSKE rose 9.7% to close at $6.55. Daseke said that the company has entered into an agreement with its Founder, Mr. Don R. Daseke, and his affiliates, to repurchase their total holdings in the company at a purchase price of $6 per share.
  • TAL Education Group TAL climbed 8.8% to close at $5.18.
  • Xinyuan Real Estate Co., Ltd. XIN gained 7.8% to close at $0.4960.
  • Babcock & Wilcox Enterprises, Inc. BW gained 7.4% to close at $5.23. Babcock & Wilcox Construction Co. LLC was awarded $42 million in large North American upgrade projects.
  • monday.com Ltd. MNDY gained 7.3% to settle at $102.10 after the company reported better-than-expected Q3 financial results.

 


Losers

  • Satsuma Pharmaceuticals, Inc. STSA shares tumbled 83.2% to close at $0.6795 on Monday after the company reported topline results from the STS101 SUMMIT Phase 3 efficacy trial in migraine patients.
  • SELLAS Life Sciences Group, Inc. SLS fell 44% to close at $2.55 after the company reported Q3 earnings results and provided a business update.
  • Nuwellis, Inc. NUWE declined 40% to close at $0.12. Nuwellis recently reported worse-than-expected Q3 EPS and sales results.
  • Infinity Pharmaceuticals, Inc. INFI fell 37.8% to close at $0.7402. Infinity Pharmaceuticals posted a Q3 loss of $0.12 per share. The company also reported an update from its MARIO-3 study of eganelisib in combination with atezolizumab and nab-paclitaxel in front-line metastatic triple-negative breast cancer (TNBC) patients.
  • POINT Biopharma Global Inc. PNT dipped 37.4% to settle at $5.72. Lantheus and POINT Biopharma announced collaboration and exclusive license agreements for commercialization of PNT2002 & PNT2003.
  • Lumos Pharma, Inc. LUMO fell 34.7% to close at $5.82. Lumos Pharma posted a Q3 loss of $0.86 per share and disclosed interim results from two Phase 2 trials evaluating oral LUM-201 for moderate pediatric growth hormone deficiency.
  • Greenwave Technology Solutions, Inc. GWAV dipped 28.6% to settle at $1.0075.
  • SOBR Safe, Inc. SOBR declined 28.6% to close at $1.50.
  • MorphoSys AG MOR shares dropped 28.1% to close at $3.94. MorphoSys’ licensing partner Roche issued an update on Phase 3 GRADUATE program for Gantenerumab in early Alzheimer’s disease.
  • Tremor International Ltd TRMR fell 26.1% to close at $6.52 after gaining over 5% on Friday.
  • Stoke Therapeutics, Inc. STOK fell 25.3% to close at $9.33 after the company reported a wider Q3 loss.
  • TuanChe Limited TC dropped 24.3% to settle at $7.51.
  • Harbor Custom Development, Inc. HCDI dropped 24.1% to close at $0.6601. Harbor Custom Development posted a Q3 loss of $0.37 per share.
  • Decisionpoint Systems, Inc. DPSI dipped 22.8% to close at $5.71 following Q3 results.
  • Actelis Networks, Inc. ASNS fell 22.7% to close at $0.6103. Actelis Networks posted a Q3 loss of $0.13 per share.
  • 908 Devices Inc. MASS fell 22.1% to settle at $12.48 as the company lowered its FY22 revenue forecast.
  • Hudson Global, Inc. HSON dropped 22% to close at $22.00.
  • Fast Radius, Inc. FSRD shares declined 19.8% to close at $0.1950 after dropping around 7% on Friday.
  • Rail Vision Ltd. RVSN fell 19% to settle at $0.7105.
  • AGBA Acquisition Limited AGBA dropped 18.7% to settle at $5.71.
  • Alight, Inc. ALIT dropped 18.2% to close at $8.06 after the company announced a 20M share common stock offering.
  • Carvana Co. CVNA declined 18% to close at $9.74.
  • Performance Shipping Inc. PSHG declined 17.7% to close at $0.2595. Performance Shipping posted Q3 EPS of $0.10.
  • Altus Power, Inc. AMPS dropped 16.6% to settle at $7.12 following Q3 results.
  • Ascendis Pharma A/S ASND fell 16.5% to close at $110.26. Ascendis Pharma announced positive topline results from the ACcomplisH Phase 2 trial of once-weekly TransCon CNP compared to a placebo in children with achondroplasia aged 2 to 10 years old.
  • CareMax, Inc. CMAX dipped 16.2% to close at $4.57. CareMax recently posted a Q3 loss of $0.25 per share.
  • Latham Group, Inc. SWIM fell 15.4% to settle at $3.52.
  • Iovance Biotherapeutics, Inc. IOVA dipped 14.9% to close at $7.56.
  • Emergent BioSolutions Inc. EBS fell 14.6% to settle at $13.45.
  • Algonquin Power & Utilities Corp. AQN fell 14.3% to close at $7.97. Algonquin Power & Utilities Corp reported worse-than-expected Q3 EPS. Several analysts downgraded the stock today.
  • Pear Therapeutics, Inc. PEAR dropped 13.4% to settle at $2.52. Pear Therapeutics posted a Q3 loss of $0.22 per share.
  • 2U, Inc. TWOU dipped 13.1% to close at $7.35.
  • Oatly Group AB OTLY fell 12.7% to close at $2.14 after the company reported worse-than-expected Q3 EPS and sales results.
  • Stitch Fix, Inc. SFIX dropped 11.4% to close at $4.13.
  • CS Disco, Inc. LAW declined 11.2% to close at $9.19.
  • TOMI Environmental Solutions, Inc. TOMZ declined 11% to close at $0.6392. TOMI Environmental Solutions recently posted a Q3 loss of $0.03 per share.
  • 8x8, Inc. EGHT fell 10.5% to close at $4.25.
  • Transphorm, Inc. TGAN fell 8.5% to close at $6.44.
  • 5E Advanced Materials Inc. FEAM dropped 7.3% to close at $11.65. 5E Advanced Materials, on Friday, reported Q1 results.
  • Bed Bath & Beyond Inc. BBBY fell 5.3% to close at $3.74. Bed Bath & Beyond reported additional privately negotiated senior notes exchanges and concurrent private placement of common stock with several institutional holders.
Loading...
Loading...
Posted In: NewsPenny StocksSmall CapPre-Market OutlookMarketsMoversTrading IdeasConsumer DiscretionaryEducation ServicesMovers From YesterdayTop Gainers
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...